If your ApoB is elevated, omega-3 is the supplement with the strongest evidence for lowering it — specifically by reducing VLDL production, which reduces the total atherogenic particle count ApoB measures. Here is the evidence, the correct dose, and what to actually buy.
ApoB measures total atherogenic particle count — every LDL, VLDL, IDL, and Lp(a) particle carries exactly one ApoB protein. Omega-3 fatty acids (EPA and DHA) lower ApoB primarily by reducing hepatic VLDL-triglyceride production. Less VLDL produced means fewer downstream LDL and IDL particles, which lowers the total ApoB count.
A key 2015 crossover RCT (Davidson et al., JAHA) found that 3.4g/day EPA+DHA significantly reduced ApoB and apo C-III compared to placebo in people with moderate hypertriglyceridemia. The dose-response matters: the ApoB effect is modest at 1g/day and becomes clinically meaningful at 3–4g/day.
The REDUCE-IT trial (Bhatt et al., NEJM 2019) showed that prescription-dose EPA (4g/day icosapentaenoic acid as Vascepa) reduced major cardiovascular events by 25% in high-risk patients with elevated triglycerides. This is the landmark outcome trial establishing high-dose EPA as a cardiovascular intervention, not just a biomarker-mover.
Most standard "fish oil" capsules contain 300–500mg EPA+DHA. One capsule daily reaches roughly 0.3–0.5g. This is below the threshold for meaningful triglyceride or ApoB reduction. This is what many people take and why they report "fish oil didn't help my cholesterol."
Meaningful triglyceride reduction (15–20%). Some ApoB lowering. Anti-inflammatory effects via hs-CRP reduction. This is the appropriate starting dose for health optimization without a specific clinical diagnosis. Requires 2–4 standard capsules or 2 concentrated capsules depending on the product.
Significant ApoB reduction, strong triglyceride lowering (25–35%), and the dose range supported by REDUCE-IT outcomes data. Most health-optimization protocols targeting elevated ApoB use this range. Note: above 3g/day, discuss with a physician if you are on anticoagulants.
The absorption difference between triglyceride (TG) form and ethyl ester (EE) form omega-3 is real but often overstated in marketing. Studies show TG form absorbs roughly 70% better than EE when taken fasted. When taken with a high-fat meal, the difference narrows substantially. Practical implication: buy TG form if you can afford it; always take omega-3 with food regardless of form.
| Form | Absorption | Found in | Notes |
|---|---|---|---|
| Triglyceride (TG) | Higher — ~70% better fasted | Nordic Naturals, Thorne, Momentous, high-quality consumer brands | Preferred form; closer to how omega-3 occurs in fish |
| Ethyl ester (EE) | Lower fasted, similar fed | Many budget brands, Lovaza (prescription), Vascepa (prescription EPA) | Still effective with food; lower cost per gram EPA+DHA |
| Phospholipid (krill) | High; no fishy taste | Krill oil brands | Much lower EPA+DHA per capsule; expensive per gram |
Most people taking omega-3 never confirm whether tissue levels are actually rising. The omega-3 index is a blood test measuring EPA+DHA as a percentage of red blood cell fatty acids. Target: above 8% (cardiovascular protective zone). Most Americans start below 4%.
Function Health includes the omega-3 index in its annual panel. Quest Health offers it as a standalone test. Establishes whether you are severely depleted (below 4%) or just below optimal (4–8%).
90 days is sufficient to see meaningful changes in ApoB and triglycerides. The omega-3 index confirms your tissue level is actually rising — if it isn't, either dose is too low or you need TG form instead of EE form.
Supplements should come after the baseline: labs, sleep, training, nutrition, and symptoms. For the supplements CreusLife recommends most often, Momentous is now the preferred partner because it offers focused products for performance, sleep, recovery, and longevity.
Start with the Momentous main store if you want to choose from the full lineup.
For cardiometabolic risk, the highest-value home measurements are blood pressure, glucose response, and rhythm awareness.
Omega-3 is one lever. The complete picture includes ApoB, Lp(a), hs-CRP, fasting insulin, and a matched protocol.